ExpressionEdits Raises $13M for AI-Based Protein Expression Technology
ExpressionEdits, a biotechnology company focused on optimizing protein expression through AI and proprietary intronization technology, has raised $13 million in …
All Posts
14 Cutting-Edge Startups Focusing On RNA Research
For many years, the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
DeepCure Unveils AI-Driven Chemical Synthesis Platform
DeepCure, a company specializing in AI-driven therapeutic discovery, has introduced a development in chemical synthesis with its Inspired Chemistry™ platform. …
Owkin Expands Oncology Pipeline with AI and EP2/EP4 Dual Inhibitor from Idorsia
Owkin, a pioneering TechBio company leveraging advanced causal* AI for precision drug discovery, has announced a significant expansion of its …
Tempus AI Files S-1 Registration to Go Public
Tempus AI has officially filed its S-1 registration statement with the Securities and Exchange Commission (SEC), marking a significant step …
Sanofi, Formation Bio, and OpenAI Partner to Innovate Drug Development with AI
Sanofi, Formation Bio, and OpenAI have announced a pioneering collaboration aimed at accelerating drug development using artificial intelligence (AI). This …
LabGenius Secures £35 Million to Enhance ML-Driven Antibody Discovery
LabGenius, a leading drug discovery company leveraging machine learning (ML) to discover novel therapeutic antibodies, has successfully completed a £35 …
Insilico Medicine Unveils nach0: A Comprehensive LLM for Chemical and Biomedical Applications
Insilico Medicine, a clinical-stage AI-driven drug discovery company, in collaboration with NVIDIA, has introduced nach0, a novel large language model …
AstraZeneca to Establish $1.5 Billion ADC Manufacturing Facility in Singapore
AstraZeneca has announced plans to construct a $1.5 billion manufacturing facility in Singapore dedicated to producing antibody-drug conjugates (ADCs), a …
Accenture's Investment in Turbine Enhances AI-Powered Cell Simulations for Biopharma R&D
Accenture has strategically invested in Turbine, a company specializing in predictive simulation with a platform aimed at interpreting human biology. …
Insilico Medicine Initiates Phase I Clinical Trial for Novel QPCTL Inhibitor
Insilico Medicine, a biotechnology company specializing in generative artificial intelligence, has begun dosing patients in the first clinical trial for …
Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry
Veranova and Phorum.AI have partnered to revolutionize pharmaceutical manufacturing processes using generative artificial intelligence. This collaboration combines Veranova's extensive 20-year …